The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gemcitabine, dexamethasone, and cisplatin (GDP) as an effective therapy as salvage and mobilization regimen in patients with relapsed or refractory Hodgkin lymphoma.
 
Ayla Gokmen
No Relationships to Disclose
 
Ender Soydan
No Relationships to Disclose
 
Zafer Gokgoz
No Relationships to Disclose
 
Mevlude Kurdal
No Relationships to Disclose
 
Ibrahim Tek
No Relationships to Disclose
 
Osman Ilhan
No Relationships to Disclose
 
Onder Arslan
No Relationships to Disclose
 
Muhit Ozcan
Honoraria - Amgen; Takeda
Research Funding - Archigen Biotech; Bayer; Celgene; Janssen; Merck; Pharmacyclics; Roche; Takeda
Travel, Accommodations, Expenses - Abdi Ibrahim; Amgen; Bristol-Myers Squibb; Roche; Sanofi; Takeda